Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer.
Cancer Discov
; 2(11): 1048-63, 2012 Nov.
Article
in En
| MEDLINE
| ID: mdl-22915751
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Genes, BRCA1
/
Poly(ADP-ribose) Polymerase Inhibitors
/
Phosphoinositide-3 Kinase Inhibitors
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Cancer Discov
Year:
2012
Document type:
Article
Affiliation country:
United States
Country of publication:
United States